Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ALT5 Sigma (ALTS) Other Accumulated Expenses (2022 - 2025)

ALT5 Sigma (ALTS) has disclosed Other Accumulated Expenses for 5 consecutive years, with $2.5 million as the latest value for Q1 2025.

  • Quarterly Other Accumulated Expenses fell 13.79% to $2.5 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Mar 2025, down 13.79% year-over-year, with the annual reading at $2.8 million for FY2024, N/A changed from the prior year.
  • Other Accumulated Expenses for Q1 2025 was $2.5 million at ALT5 Sigma, down from $2.8 million in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $2.9 million in Q1 2024, with the low at $47000.0 in Q4 2022.
  • Average Other Accumulated Expenses over 3 years is $2.3 million, with a median of $2.8 million recorded in 2024.
  • Peak annual rise in Other Accumulated Expenses hit 13.79% in 2025, while the deepest fall reached 13.79% in 2025.
  • Over 3 years, Other Accumulated Expenses stood at $47000.0 in 2022, then surged by 5963.83% to $2.8 million in 2024, then fell by 12.28% to $2.5 million in 2025.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $2.5 million, $2.8 million, and $2.8 million for Q1 2025, Q4 2024, and Q3 2024 respectively.